Addus HomeCare (ADUS) Competitors $110.92 -1.28 (-1.14%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$110.88 -0.05 (-0.04%) As of 07/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADUS vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, WGS, and VCYTShould you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Addus HomeCare vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent GeneDx Veracyte Guardant Health (NASDAQ:GH) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations. Do analysts rate GH or ADUS? Guardant Health presently has a consensus price target of $53.76, indicating a potential upside of 6.99%. Addus HomeCare has a consensus price target of $142.57, indicating a potential upside of 28.54%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 21 Buy rating(s) 0 Strong Buy rating(s) 3.00Addus HomeCare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Does the media prefer GH or ADUS? In the previous week, Guardant Health had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 7 mentions for Guardant Health and 5 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.31 beat Guardant Health's score of 1.20 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Addus HomeCare 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GH or ADUS more profitable? Addus HomeCare has a net margin of 6.52% compared to Guardant Health's net margin of -53.82%. Addus HomeCare's return on equity of 9.23% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-53.82% N/A -26.77% Addus HomeCare 6.52%9.23%6.96% Do insiders and institutionals believe in GH or ADUS? 92.6% of Guardant Health shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 6.1% of Guardant Health shares are held by insiders. Comparatively, 4.6% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings & valuation, GH or ADUS? Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M8.42-$436.37M-$3.39-14.82Addus HomeCare$1.15B1.77$73.60M$4.4325.04 Which has more volatility & risk, GH or ADUS? Guardant Health has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. SummaryAddus HomeCare beats Guardant Health on 12 of the 17 factors compared between the two stocks. Get Addus HomeCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADUS vs. The Competition Export to ExcelMetricAddus HomeCareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.06B$3.87B$5.60B$9.11BDividend YieldN/A1.32%5.24%4.02%P/E Ratio25.0435.5827.9620.25Price / Sales1.7795.46430.5799.61Price / Cash20.8223.6037.4658.16Price / Book2.074.328.045.49Net Income$73.60M$189.47M$3.18B$250.27M7 Day Performance-0.84%-3.28%3.63%4.75%1 Month Performance-2.73%-6.53%4.04%7.64%1 Year Performance-8.25%-1.25%29.56%16.34% Addus HomeCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADUSAddus HomeCare4.9775 of 5 stars$110.92-1.1%$142.57+28.5%-7.4%$2.06B$1.15B25.0449,703GHGuardant Health4.0862 of 5 stars$49.54-1.9%$53.76+8.5%+67.7%$6.26B$739.02M-14.612,021Positive NewsOPCHOption Care Health4.5464 of 5 stars$30.91-0.8%$35.50+14.8%+3.2%$5.10B$5.00B22.758,088News CoveragePositive NewsAnalyst ForecastRDNTRadNet4.1894 of 5 stars$55.26-1.7%$69.60+26.0%-7.3%$4.22B$1.83B-128.5111,021Positive NewsAnalyst ForecastBTSGBrightSpring Health Services1.6802 of 5 stars$22.00-0.5%$24.90+13.2%+83.0%$3.89B$11.27B78.5735,000SHCSotera Health3.1488 of 5 stars$11.40-2.9%$16.00+40.4%-3.2%$3.33B$1.10B18.943,000SGRYSurgery Partners2.4543 of 5 stars$22.03-0.5%$33.56+52.3%-13.7%$2.84B$3.11B36.9215,000PRVAPrivia Health Group4.5048 of 5 stars$21.35-3.4%$27.77+30.1%+14.2%$2.70B$1.74B184.251,140News CoverageAnalyst ForecastCONConcentra Group Holdings Parent2.9413 of 5 stars$20.33-1.1%$28.50+40.2%N/A$2.64B$1.90B15.1711,250News CoverageWGSGeneDx3.8538 of 5 stars$85.74-6.4%$90.13+5.1%+141.3%$2.61B$305.45M100.671,200Trending NewsAnalyst ForecastInsider TradeVCYTVeracyte3.5821 of 5 stars$26.34-4.3%$40.90+55.3%+20.0%$2.15B$445.76M30.23790 Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives GeneDx Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADUS) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
